UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
Schall, Brown & Schwartz LLP, a shareholder rights firm, issued a notice reminding UNCY investors of a pending securities fraud class action covering purchases between December 29, 2025 and June 29, 2026, with a November 2, 2026 lead plaintiff deadline. The underlying complaint alleges Unicycive made false and misleading statements, including failing to inspect its third-party manufacturing partner for good manufacturing practices compliance and lacking support that the vendor resolved FDA-identified deficiencies.
Key figures
- Class period end
- 2026-06-29
- Class period start
- 2025-12-29
- Lead plaintiff deadline
- 2026-11-02
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.